# Transplanting Hepatitis C Positive Organs

> **NCT03086044** · PHASE4 · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 148 (estimated)

## Conditions studied

- Hepatitis C
- Awaiting Organ Transplant

## Interventions

- **DRUG:** Sofosbuvir/velpatasvir
- **OTHER:** Monitoring

## Key facts

- **NCT ID:** NCT03086044
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086044, "Transplanting Hepatitis C Positive Organs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03086044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*